UY28200A1 - Acidos carboxílicos de heteroarilo condensado como agonistas del ppar - Google Patents
Acidos carboxílicos de heteroarilo condensado como agonistas del pparInfo
- Publication number
- UY28200A1 UY28200A1 UY28200A UY28200A UY28200A1 UY 28200 A1 UY28200 A1 UY 28200A1 UY 28200 A UY28200 A UY 28200A UY 28200 A UY28200 A UY 28200A UY 28200 A1 UY28200 A1 UY 28200A1
- Authority
- UY
- Uruguay
- Prior art keywords
- carboxylic acids
- condensed
- heteroarilo
- ppar agonists
- ppar
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Abstract
Ácidos carboxílicos de heteroarilo condensado de fórmula (i): en la que R1, Ar,A, Y, HET, Q y T son como se han definido en la memoria descriptiva; composiciones farmacéuticas que contienen cantidades eficaces de dichos compuestos o sus sales son útiles para tratar trastornos relativos a PPAR, tales como diabetes, dislipidemia, obesidad y trastornos inflamatorios.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44893103P | 2003-02-21 | 2003-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY28200A1 true UY28200A1 (es) | 2004-09-30 |
Family
ID=32908672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY28200A UY28200A1 (es) | 2003-02-21 | 2004-02-19 | Acidos carboxílicos de heteroarilo condensado como agonistas del ppar |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040209929A1 (es) |
EP (1) | EP1597257A1 (es) |
JP (1) | JP2006518366A (es) |
AR (1) | AR044498A1 (es) |
BR (1) | BRPI0407735A (es) |
CA (1) | CA2516475A1 (es) |
GT (1) | GT200400019A (es) |
MX (1) | MXPA05008922A (es) |
NL (1) | NL1025542C2 (es) |
PA (1) | PA8594401A1 (es) |
PE (1) | PE20050223A1 (es) |
TW (1) | TW200424201A (es) |
UY (1) | UY28200A1 (es) |
WO (1) | WO2004074284A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1692506A4 (en) * | 2003-11-17 | 2008-01-09 | Janssen Pharmaceutica Nv | MODELING A SYSTEMIC INFLAMMATORY RESPONSE TO INFECTION |
WO2005060958A1 (en) * | 2003-12-19 | 2005-07-07 | Kalypsys, Inc. | (5- (2-phenyl)-thiazol-5-ylmethoxy)-indol-1-yl) -acetic acid derivatives and related compounds as modulators of the human ppar-delta receptor for the treatment of metabolic disorders such as type 2 diabetes |
ES2343640T3 (es) * | 2004-08-12 | 2010-08-05 | Amgen Inc. | Bisaril-sulfonamidas. |
CN101018790A (zh) * | 2004-09-11 | 2007-08-15 | 塞诺菲-安万特德国有限公司 | 7-氮杂吲哚以及其用作ppar激动剂的应用 |
US8003806B2 (en) | 2004-11-12 | 2011-08-23 | OSI Pharmaceuticals, LLC | Integrin antagonists useful as anticancer agents |
PE20080188A1 (es) * | 2006-04-18 | 2008-03-10 | Janssen Pharmaceutica Nv | Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol |
CA2740366A1 (en) * | 2008-10-21 | 2010-04-29 | Metabolex, Inc. | Aryl gpr120 receptor agonists and uses thereof |
TWI667233B (zh) | 2013-12-19 | 2019-08-01 | 德商拜耳製藥公司 | 新穎吲唑羧醯胺,其製備方法、含彼等之醫藥製劑及其製造醫藥之用途 |
JP6369951B2 (ja) * | 2015-08-26 | 2018-08-08 | 三井農林株式会社 | ジペプチジルペプチダーゼ−iv阻害剤 |
WO2017121308A1 (en) * | 2016-01-11 | 2017-07-20 | Chongqing Fochon Pharmaceutical Co., Ltd. | Fused pyridine compounds, compositions and methods of use |
WO2018202039A1 (zh) * | 2017-05-03 | 2018-11-08 | 成都海创药业有限公司 | 杂环化合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420289A (en) * | 1989-10-27 | 1995-05-30 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
KR100356551B1 (ko) * | 1994-10-20 | 2002-12-18 | 닛뽕 케미파 가부시키가이샤 | 퀴놀린유도체 |
AU782631C (en) * | 1999-12-03 | 2006-08-17 | Kyoto Pharmaceutical Industries, Ltd. | Novel heterocyclic compounds and salts thereof and medicinal use of the same |
EP1405848B1 (en) * | 2001-06-18 | 2008-05-07 | Ono Pharmaceutical Co., Ltd. | Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
EA200400140A1 (ru) * | 2001-08-29 | 2004-08-26 | УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си | Пероральные противодиабетические агенты |
US20030171377A1 (en) * | 2001-08-29 | 2003-09-11 | Bigge Christopher Franklin | Antidiabetic agents |
-
2004
- 2004-01-22 PA PA20048594401A patent/PA8594401A1/es unknown
- 2004-02-09 JP JP2006502422A patent/JP2006518366A/ja active Pending
- 2004-02-09 EP EP04709295A patent/EP1597257A1/en not_active Withdrawn
- 2004-02-09 BR BRPI0407735-0A patent/BRPI0407735A/pt not_active Application Discontinuation
- 2004-02-09 MX MXPA05008922A patent/MXPA05008922A/es unknown
- 2004-02-09 CA CA002516475A patent/CA2516475A1/en not_active Abandoned
- 2004-02-09 WO PCT/IB2004/000338 patent/WO2004074284A1/en not_active Application Discontinuation
- 2004-02-18 PE PE2004000169A patent/PE20050223A1/es not_active Application Discontinuation
- 2004-02-18 GT GT200400019A patent/GT200400019A/es unknown
- 2004-02-19 UY UY28200A patent/UY28200A1/es not_active Application Discontinuation
- 2004-02-19 US US10/783,654 patent/US20040209929A1/en not_active Abandoned
- 2004-02-20 NL NL1025542A patent/NL1025542C2/nl not_active IP Right Cessation
- 2004-02-20 AR ARP040100541A patent/AR044498A1/es unknown
- 2004-02-20 TW TW093104303A patent/TW200424201A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2516475A1 (en) | 2004-09-02 |
AR044498A1 (es) | 2005-09-14 |
PA8594401A1 (es) | 2004-09-16 |
JP2006518366A (ja) | 2006-08-10 |
NL1025542C2 (nl) | 2005-10-11 |
NL1025542A1 (nl) | 2004-08-24 |
TW200424201A (en) | 2004-11-16 |
PE20050223A1 (es) | 2005-03-22 |
US20040209929A1 (en) | 2004-10-21 |
GT200400019A (es) | 2004-09-21 |
EP1597257A1 (en) | 2005-11-23 |
WO2004074284A1 (en) | 2004-09-02 |
MXPA05008922A (es) | 2005-10-05 |
BRPI0407735A (pt) | 2006-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP056105A (es) | Acidos carboxilicos alfa sustituidos como moduladores ppar | |
CY1112429T1 (el) | Υποκατεστημενα παραγωγα σουλφοναμιδιου | |
ATE482210T1 (de) | Oxadiazolderivate als s1p1-rezeptor-agonisten | |
PE20121499A1 (es) | Formas cristalinas de 3-(2, 6-dicloro-3, 5-dimetoxi-fenil)-1-{6-4[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas | |
CL2008002159A1 (es) | Compuestos derivados de n-(((1r, 4r)-4-aminociclohexil)metil) sulfonaminas sustituidas con heterociclos, antagonistas del receptor npy y5; composicion farmaceutica que comprende a dichos compuestos, utiles para tratar anorexia y obesidad. | |
EA200901609A1 (ru) | Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов | |
EA201100877A1 (ru) | Спирогетероциклические n-оксиамиды в качестве пестицидов | |
PE20142019A1 (es) | Nuevos derivados de acidos indaniloxidihidrobenzofuranilaceticos y sus usos como agonistas del receptor gpr40 | |
PE20130311A1 (es) | Composiciones y metodos para modular la via de senalizacion de wnt | |
EA201300436A8 (ru) | Совместные кристаллы и соли ингибиторов ccr3 | |
ATE459352T1 (de) | Benzimidazol-cannabinoid-agonisten mit einer substituierten heterocyclischen gruppe | |
ATE500222T1 (de) | Benzamid- und heteroarenderivate als cetp- inhibitoren | |
UY28200A1 (es) | Acidos carboxílicos de heteroarilo condensado como agonistas del ppar | |
CL2008003472A1 (es) | Compuestos derivados de 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-ona, proceso para la preparacion de los mismos, compuestos intermediarios, composicion farmaceutica que comprende dicho compuesto; combinacion farmaceutica, y sus usos en el tratamiento de enfermedades inflamatorias. | |
UA106880C2 (uk) | Нові гербіциди | |
CL2011003138A1 (es) | N-(protegido- n-(3-metoxi-5-metilpirazon-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridino-3-sulfonamida y su proceso de preparacion. | |
EA201170828A1 (ru) | Конденсированные гетероциклические производные оксадиазола, подходящие для лечения рассеянного склероза | |
DE502007006315D1 (de) | 1,3-disubstituierte 4-methyl-1 h-pyrrol-2-carbonsärzneimitteln | |
GT200700105A (es) | Inhibidor del factor xa | |
AR108389A2 (es) | Derivados de ácido fenilacético | |
DE602005014629D1 (de) | Pyrazolphenylderivate als ppar-aktivatoren | |
UY31448A1 (es) | Compuestos de 1,2,4,-triazin-3,5-diona adecuados para el tratamiento de trastornos que responden a la modulacion del receptor de dopamina d3. | |
ATE525370T1 (de) | Phthalazin- und pyridoä3,4- düpyridazinverbindungen als h1-rezeptor- antagonisten | |
DOP2004000813A (es) | Carboxilicos de heteroarilo condensado como agonistas del ppar | |
EA201101014A1 (ru) | Сульфонамиды, предназначенные для лечения респираторных нарушений |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20140610 |